The Journal of mHealth Vol 3 Issue 1 (Feb/Mar 2016) | Page 30

Global mHealth Mapping Project Identifies Millions at Risk of Blindness
Continued from page 27

Orange and Digital Healthcare

to a common and coordinated approach for evaluating the
progress and efficiency of healthcare’s digital frontier. Interdisciplinary evaluation models such as MAST (Model for Assessment of Telemedicine) can provide valuable tools to assess
projects weaknesses and strengths, and a common framework
and vocabulary. By having such feedback mechanisms in place,
enables the industry to identify how to best move forward and
achieve scalability of services so that citizens everywhere can
once again enjoy the benefits of efficient healthcare systems.

For more than a decade, Orange has gained substantial experience in providing integrated technology solutions for health
professionals, health providers and patients. This has been done
through close collaboration with health professionals and providers – ensuring that the technology brings improved quality
and efficiency for all. In 2007 Orange signalled its commitment
to the health sector with the creation of Orange Healthcare, its
digital health division.
References
1. http://europa.eu/epc/pdf/ageing_report_2015_en.pdf
2. http://ec.europa.eu/health/major_chronic_diseases/docs/reflection_
process_cd_en.pdf
3. h t t p : / / w w w. g s m a . c o m / c o n n e c t e d l i v i n g / w p - c o n t e n t /
uploads/2013/06/Socio-economic_impact-of-mHealth_
EU_14062013V2.pdf
4. http://ec.europa.eu/public_opinion/archives/eb/eb83/eb83_publ_
fr.pdf
5. h t t p : / / w w w. g s m a . c o m / c o n n e c t e d l i v i n g / w p - c o n t e n t /
uploads/2013/06/Socio-economic_impact-of-mHealth_
EU_14062013V2.pdf n

Global mHealth Mapping Project
Identifies Millions of People Living
at Risk of Blindness from Trachoma
Largest infectious disease survey ever undertaken uses smartphones to record where the eye
disease trachoma is most prevalent worldwide
A ground breaking three-year diseasemapping project has shown that 100 million1 people are at risk of blindness from
trachoma.
The Global Trachoma Mapping Project
(GTMP), launched in December 2012
and completed in January 20162 saw
surveyors collect and transmit data from
2.6 million people in 293 countries using
Android smartphones. On average one
person was examined every 40 seconds
during the three-year project.
The £10.6 million project funded by the
UK government’s Department for International Development (DFID), with
additional funding from USAID, was led
by Sightsavers in collaboration with

28

February/March 2016

30 ministries of health who provided
staff, technical support, supervision
and vehicles. In total over 604 partners
worked together across the world, representing a combined effort of an estimated 2,500 people globally.

The GTMP is the largest infectious disease survey ever undertaken, helping to
pinpoint accurately the world’s trachoma
endemic areas. The sample of people
surveyed during the project represents a
global population of 2245 million people.